Testimony
Written Comments to FDA October 18, 2018
The following written comments were submitted by IFFGD president, Ceciel T. Rooker, to the US Food and Drug Administration (FDA) in connection with a October 18, 2018 joint meeting of the FDA Gastrointestinal Drugs Advisory Committee and Risk Management Advisory Committee to discuss the reintroduction of Zelnorm: The International Foundation for Gastrointestinal Disorders (IFFGD) […]